Forget megadeals, Pfizer CEO-to-be Bourla says. They're just too distracting
admin 30th October 2018 Uncategorised 0In the farewell earnings report for outgoing CEO Ian Read, successor Albert Bourla gave a first glimpse into what he has planned for the Big Pharma—and it doesn’t include large-scale M&A. The reason? Pfizer has a strong pipeline, and integrating a huge buyout is too much of a distraction.
More: Forget megadeals, Pfizer CEO-to-be Bourla says. They're just too distracting
Source: fierce